DD202013A5 - Verfahren zur herstellung basisch substituierter pyridazine - Google Patents

Verfahren zur herstellung basisch substituierter pyridazine Download PDF

Info

Publication number
DD202013A5
DD202013A5 DD81235901A DD23590181A DD202013A5 DD 202013 A5 DD202013 A5 DD 202013A5 DD 81235901 A DD81235901 A DD 81235901A DD 23590181 A DD23590181 A DD 23590181A DD 202013 A5 DD202013 A5 DD 202013A5
Authority
DD
German Democratic Republic
Prior art keywords
hydrogen
atoms
general formula
formula
compound
Prior art date
Application number
DD81235901A
Other languages
German (de)
English (en)
Inventor
Thomas Raabe
Helmut Bohn
Piero A Martorana
Rolf-Eberhard Nitz
Original Assignee
Cassella Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Ag filed Critical Cassella Ag
Publication of DD202013A5 publication Critical patent/DD202013A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22—Nitrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Pyridine Compounds (AREA)
DD81235901A 1980-12-22 1981-12-17 Verfahren zur herstellung basisch substituierter pyridazine DD202013A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803048487 DE3048487A1 (de) 1980-12-22 1980-12-22 Basisch substituierte pyridazine, ihre herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
DD202013A5 true DD202013A5 (de) 1983-08-24

Family

ID=6119960

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81235901A DD202013A5 (de) 1980-12-22 1981-12-17 Verfahren zur herstellung basisch substituierter pyridazine

Country Status (26)

Country Link
US (1) US4532239A (da)
EP (1) EP0054946B1 (da)
JP (1) JPS57128677A (da)
KR (1) KR880002233B1 (da)
AT (1) ATE8991T1 (da)
AU (1) AU544386B2 (da)
CA (1) CA1173033A (da)
CS (1) CS236665B2 (da)
DD (1) DD202013A5 (da)
DE (2) DE3048487A1 (da)
DK (1) DK149810C (da)
ES (3) ES8304941A1 (da)
FI (1) FI73418C (da)
GR (1) GR81382B (da)
HK (1) HK51485A (da)
IE (1) IE51985B1 (da)
IL (1) IL64605A (da)
NO (1) NO814182L (da)
NZ (1) NZ198919A (da)
PH (1) PH17529A (da)
PL (3) PL136127B1 (da)
PT (1) PT74185B (da)
RO (3) RO88190B (da)
SG (1) SG7585G (da)
SU (2) SU1170970A3 (da)
ZA (1) ZA818806B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3023369A1 (de) * 1980-06-23 1982-01-14 Boehringer Mannheim Gmbh, 6800 Mannheim Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPH0641454B2 (ja) * 1985-02-27 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
EP0201765B1 (en) * 1985-04-27 1991-09-18 Nissan Chemical Industries Ltd. 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
JPS61282194A (ja) * 1985-06-06 1986-12-12 Yukio Nakamura ジエツト推進式舟艇の推進軸とその製造法
JPH0629254B2 (ja) * 1986-09-08 1994-04-20 帝国臓器製薬株式会社 ピリダジノン誘導体
DE3902316A1 (de) * 1989-01-26 1990-08-02 Lentia Gmbh Neue piperazinylalkyl-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung als blutdrucksenkende mittel
NZ234087A (en) * 1989-06-19 1991-08-27 Teikoku Hormone Mfg Co Ltd 2-(3-aryloxy(2-hydroxy-propylamino))-2-methylpropyl- aminophenyl pyridazine derivatives
US5221674A (en) * 1989-06-19 1993-06-22 Teikoku Hormone Mfg. Co., Ltd. Pyridazinone derivatives
HU214320B (hu) * 1991-12-20 1998-03-02 EGIS Gyógyszergyár Rt. Eljárás új 3(2H)-piridazinon-származékok és ezeket tartalmazó gyógyszerkészítmények előállítására
KR20010052598A (ko) * 1998-06-05 2001-06-25 사바 키스 ; 아틸라 만디 야노스 템페 ; 기울라 시미그 3(2ｈ)-피리다지논-4-치환된 아미노-5-클로로-유도체의제조 방법
CN101730692A (zh) * 2007-03-15 2010-06-09 先灵公司 用作葡聚糖合成酶抑制剂的哒嗪酮衍生物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE368197B (da) * 1968-11-18 1974-06-24 Pfizer
GB1421999A (en) * 1973-02-08 1976-01-21 Smith Kline French Lab Heterocyclic containing sulphoxides
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
GB1488330A (en) * 1973-12-19 1977-10-12 Smith Kline French Lab Dihydropyridazinones
US4088764A (en) * 1973-12-27 1978-05-09 Cassella Farbwerke Mainkur Aktiengesellschaft Pharmaceutically active derivatives of 1-phenoxy-3-amino-propan-2-ol
CH592625A5 (da) * 1974-05-14 1977-10-31 Ciba Geigy Ag
LU77339A1 (da) * 1977-05-16 1979-01-19
DD146749A3 (de) * 1977-12-01 1981-03-04 Dieter Lehmann Verfahren zur herstellung von phenoxyalkanolamin-derivaten
DE3023369A1 (de) * 1980-06-23 1982-01-14 Boehringer Mannheim Gmbh, 6800 Mannheim Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
DK542881A (da) 1982-06-23
KR830007577A (ko) 1983-11-04
AU7870481A (en) 1982-07-01
FI73418B (fi) 1987-06-30
SU1170970A3 (ru) 1985-07-30
IE51985B1 (en) 1987-05-13
PL234312A1 (en) 1983-02-14
PT74185B (de) 1987-03-24
PL238538A1 (en) 1983-04-25
HK51485A (en) 1985-07-12
IL64605A (en) 1985-11-29
PL137106B1 (en) 1986-04-30
FI73418C (fi) 1987-10-09
KR880002233B1 (ko) 1988-10-20
RO88190A (ro) 1985-12-30
NZ198919A (en) 1985-05-31
ATE8991T1 (de) 1984-09-15
RO88201A (ro) 1985-12-30
EP0054946A1 (de) 1982-06-30
ES508274A0 (es) 1983-03-16
AU544386B2 (en) 1985-05-23
DE3165595D1 (en) 1984-09-20
PL238537A1 (en) 1983-06-20
RO88201B (ro) 1985-12-31
SG7585G (en) 1985-08-08
RO84277A (ro) 1984-05-23
PL136127B1 (en) 1986-01-31
EP0054946B1 (de) 1984-08-15
PL137150B1 (en) 1986-05-31
PT74185A (de) 1982-01-01
ZA818806B (en) 1982-11-24
IL64605A0 (en) 1982-03-31
CS236665B2 (en) 1985-05-15
ES8304941A1 (es) 1983-03-16
CA1173033A (en) 1984-08-21
NO814182L (no) 1982-06-23
RO88190B (ro) 1985-12-31
SU1151204A3 (ru) 1985-04-15
DK149810C (da) 1987-03-23
RO84277B (ro) 1984-07-30
FI813941L (fi) 1982-06-23
DK149810B (da) 1986-10-06
JPS57128677A (en) 1982-08-10
ES518139A0 (es) 1983-10-01
DE3048487A1 (de) 1982-07-29
US4532239A (en) 1985-07-30
GR81382B (da) 1984-12-11
ES8400096A1 (es) 1983-10-16
ES8308859A1 (es) 1983-10-01
PH17529A (en) 1984-09-13
IE813014L (en) 1982-06-22
ES518138A0 (es) 1983-10-16

Similar Documents

Publication Publication Date Title
EP0253327B1 (de) Neue Diphenylpropylamin-Derivate, ihre Herstellung sowie ihre pharmazeutische Verwendung
DE1957706B2 (de) Kernsubstituierte 3-phenoxy-l-phenoxyalkylamino-propan-2-ole und arzneimittel auf deren basis
EP0014951A2 (de) Heterocyclische Oxypropanolamin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2644833A1 (de) Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
EP0054946B1 (de) Basisch substituierte Pyridazine, ihre Herstellung und ihre Verwendung
DD201305A5 (de) Verfahren zur herstellung von in 7-stellung substituierten benzopyranen
DE2819629A1 (de) Alkylendiaminderivate, verfahren zu ihrer herstellung und ihre verwendung
DE2651083A1 (de) Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
DE3230209C2 (de) Carbostyrilderivate, Verfahren zu deren Herstellung und diese enthaltende kardiotonische Mittel
CH640227A5 (de) Aminoalkoxyphenyl-derivate.
EP0231003A2 (de) Basisch substituierte Phenylacetonitrile, ihre Herstellung und diese enthaltende Arzneimittel
EP0018360A1 (de) N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung.
EP0025864B1 (de) Tetrahydrochinolinderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Zubereitungen
EP0027928B1 (de) Piperidinderivate von 4,5-Dialkyl-3-hydroxy-pyrrol-2-carbonsäureestern, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE3688450T2 (de) 3(2h)-pyridazinonderivate, verfahren und zwischenprodukte zu deren herstellung und diese und/oder andere 3(2h)-pyridazinonderivate enthaltende heilmittel.
DE2300018C2 (de) 1-[N-Methyl-N-(β-phenyläthyl)-3-aminopropyl]- benzimidazol-Abkömmlinge
EP0303920A1 (de) Neue Benzofuranderivate und diese enthaltende therapeutische Mittel
DE2923817C2 (de) (3-Alkylamino-2-hydroxyproposy)-furan-2-carbonsäureanilide und deren physiologisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen
DD146749A3 (de) Verfahren zur herstellung von phenoxyalkanolamin-derivaten
EP0008108B1 (de) Aminopropanolderivate des 2-(o-Hydroxyphenyl)-pyrrols, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2825861A1 (de) Pyridazinylhydrazone, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben
DD157796A5 (de) Verfahren zur herstellung neuer derivate des 2-amino-aethanols
EP0078989B1 (de) Pyridazinonimine und ihre physiologisch verträglichen Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende therapeutische Mittel
DD202548A5 (de) Verfahren zur herstellung von neuen heteroaryloxypropanolaminen
DE2950064A1 (de) Piperidinderivate von 3-hydroxythiophen-2-carbonsaeure und -estern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen